Biotech Series C Investors & VC Firms
600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.
Blue Horizon Corporation
ZurichPre-Seed–Late Stage
2 people
i-nest capital
TokyoPre-Seed–Growth
7 people
Kaiser Permanente Ventures
San FranciscoSeed–Growth$2M – $5M
9 people
OneVentures
SydneySeed–Late Stage$3.3M – $13.2M
11 people
Windham Capital Partners
New YorkSeries A–Growth
17 people
+ND Capital
WoodsideSeed–Late Stage$540K – $5.4M
18 people
Pontifax Venture Capital
HerzeliyaPre-Seed–Late Stage$6.3M – $128M
8 people
Pangaea Ventures Us Inc.
VancouverSeed–Late Stage$500K – $1.5M
13 people
Avaana Capital
MumbaiSeed–Late Stage
22 people
FCA Venture Partners
NashvilleSeed–Series C$500K – $10M
12 people
Ontario Centre of Innovation
TorontoPre-Seed–Growth$500K
24 people
E2MC Ventures
OrlandoPre-Seed–Late Stage$250K – $2M
14 people
Green Pine Capital Partners
ShenzhenPre-Seed–Late Stage$425K – $150M
2 people
Black Opal Ventures
New YorkSeed–Late Stage
25 people
2080 Ventures
Pre-Seed–Growth$100K – $500K
18 people
PortfoLion Capital Partners
BudapestSeed–Late Stage$540K – $32.4M
32 people
Morningside Venture Capital Limited
ShanghaiPre-Seed–Growth$5M – $400M
McKesson Ventures
San FranciscoSeed–Late Stage
15 people
MIG Capital AG
MunichSeed–Growth$1.1M – $10.8M
23 people
LAV
Hong KongSeed–Series C$5M – $15M
3 people
Samsara BioCapital
Palo AltoSeed–Late Stage
5 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
24 people
Forepont Capital Partners
New YorkPre-Seed–Late Stage
24 people
Osage University Partners
Pre-Seed–Late Stage$1M – $20M
21 people
Related lists
Series C Investors & VC Firms (2751)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Biotech Investors & VC Firms in United States (1039)Series C Investors & VC Firms in United States (946)Biotech Series B Investors & VC Firms (900)Series C Investors & VC Firms in Global (896)Biotech Pre-Seed Investors & VC Firms (896)Healthtech Series C Investors & VC Firms (771)
Data sourced from public filings and firms' own websites — see our methodology.

















.jpg)

















_edited.png)






























